Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 4/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | EGFR | P00533 | 5/20 | 0.35 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.35 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.35 |
| ▸ | HTR6 | P50406 | 2/20 | 0.35 |
| ▸ | CDK9 | P50750 | 2/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Formic Acid SCHEMBL4667475 | 0.94 | HTR6 (0.38) | PRKCACYP1A2CYP2D6CYP2C19CYP3A4 | |
| Formic Acid SCHEMBL4666175 | 0.90 | PRKCA (0.39) | PRKCACYP1A2CYP2D6CYP2C19CYP3A4 | |
| Formic Acid SCHEMBL4667447 | 0.87 | PRKCB (0.42) | PRKCACYP1A2CYP2D6CYP2C19CYP3A4 | |
| SCHEMBL4665992 | 0.86 | CYP1A2 (0.35) | PRKCACYP1A2CYP2D6CYP2C19CYP3A4 | |
| Formic Acid SCHEMBL4667436 | 0.84 | KMT2A (0.40) | PRKCAMAPK1EGFRUSP2ALDH1A1 | |
| Formic Acid SCHEMBL4665774 | 0.82 | BPTF (0.41) | CYP1A2CYP2D6CYP2C19CYP3A4MAPK1 | |
| Formic Acid SCHEMBL4666097 | 0.81 | PRKCB (0.43) | PRKCAEGFRABCB1ABCG2HTR6 | |
| Formic Acid SCHEMBL4663919 | 0.81 | EGFR (0.40) | CYP1A2CYP2D6CYP2C19CYP3A4MAPK1 | |
| SCHEMBL4667477 | 0.80 | EGFR (0.35) | PRKCACYP1A2CYP2D6CYP2C19CYP3A4 | |
| SCHEMBL4666179 | 0.79 | PRKCA (0.35) | PRKCACYP1A2CYP2D6CYP2C19EGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080242681-A1 | N-4-(6-(Hetero)Aryl-Pyrimidin-4-Ylaminophenyl)-Benzenesulfonamides as Kinase Inhibitors | ALTANA PHARMA AG (DE) | 2008-10-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080242681-A1 | N-4-(6-(Hetero)Aryl-Pyrimidin-4-Ylaminophenyl)-Benzenesulfonamides as Kinase Inhibitors | MAP3K19, MAP3K6, MAP3K20 | PRKCA 349/4885CYP1A2 1215/4885CYP2D6 646/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.